By Canadian Press

Single-shot vaccine’s other advantages may soon outweigh lower efficacy, Fauci says

Feb 1, 2021 | 12:04 PM

WASHINGTON — The pre-eminent infectious disease expert in the United States is urging people not to sell short the single-shot COVID-19 vaccine. 

Dr. Anthony Fauci says Johnson and Johnson’s vaccine has virtues beyond an efficacy rate that lags that of its predecessors. 

The vaccine, which has proven 72 per cent effective at preventing COVID-19 in the U.S., also helps to prevent death and hospitalization, needs only basic refrigeration and requires just one dose. 

Fauci says some people may find it a good alternative to the current crop of double-dose, deep-freeze vaccines, which are 95 per cent effective at preventing infection. 

The Johnson and Johnson vaccine has yet to be approved by the U.S. Food and Drug Administration but is likely to be next in the pipeline. 

GST Holiday

Federal government's two-month GST holiday begins

1h ago

Imminent need

Council set to discuss possible location for homeless shelter on 15th Street

6h ago

International Spotlight

P.A.'s Howe one of 4 Sask. born players named to Canada's World Junior roster

22h ago

Dr. Theresa Tam, Canada’s chief public health officer, says time will tell whether different vaccines should be aimed at different demographic groups. 

This report by The Canadian Press was first published Feb. 1, 2021. 

The Canadian Press